Newron Pharmaceuticals S.p.A. (FRA:NP5)
7.27
+0.05 (0.69%)
At close: Jun 27, 2025, 10:00 PM CET
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of €145.85 million as of June 27, 2025. Its market cap has decreased by -23.30% in one year.
Market Cap
145.85M
Enterprise Value
186.58M
Revenue
51.39M
Ranking
n/a
PE Ratio
9.21
Stock Price
€7.27
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 194.15M to 145.85M, a decrease of -24.88%. That is a compound annual growth rate of -1.53%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 300.98B |
Siemens Aktiengesellschaft | 173.56B |
Deutsche Telekom AG | 151.71B |
Allianz SE | 131.30B |
Rheinmetall AG | 79.74B |
Siemens Energy AG | 75.46B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.32B |
Siemens Healthineers AG | 52.28B |